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Abstract To elucidate the evolution of SEN virus (SEN-V),
serial sequences of chronically SEN-V-infected patients were
analyzed. In the hypervariable regions, non-synonymous sub-
stitutions significantly predominated. This could be attributed to
positive selection in evading immune surveillance of the hosts and
to establish a persistent infection. On the basis of the sequences
in the two open reading frames of SEN-V DNA, the rate of
synonymous substitutions was 7.32U1034 per site per year.
Since this rate is close to RNA viruses and higher than other
DNA viruses, the SEN-V might be replicated by machinery with
poor or no proofreading function. ß 2002 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
In 1999, a novel DNA virus designated SEN virus (SEN-V)
was discovered in the serum of a human immunode¢ciency
virus type 1 (HIV-1)-infected injection drug user and named
after the initials of this patient [1]. SEN-V is a single-stranded,
circular DNA virus of approximately 3800 nucleotides (nt),
possibly belonging to the Circoviridae family [2] that includes
TT virus (TTV) [3], TUS01 [4], SANBAN [5] and YONBAN
[6]. Recently, Ukita et al. determined the full sequence of TTV
isolates of genotype 12 (TJN01) and genotype 13 (TJN02)
from healthy individuals in Japan [7]. Phylogenetic analysis
con¢rmed that SENV-D and TJN01, SANBAN and TJN02,
respectively, were the same genotypes [2]. A strong association
between two SEN-V variants (SENV-D and SENV-H) infec-
tions and transfusion-associated non-A to E hepatitis has
been reported [8]. Additionally, 2% of USA blood donors
[8] and 20% of healthy Japanese individuals [9] were infected
with SENV-D and/or SENV-H. SEN-V transmission can oc-
cur by blood transfusion and the relatively high prevalence of
SEN-V among drug addicts, and patients with hepatitis C
virus (HCV) suggests that this is an important transmission
route [8,10,11]. It is not known, however, whether SEN-V
causes disease in humans.
Recent studies indicate that the TTV and SEN-V genomes
are heterogeneous both among infected individuals and within
the same individuals [7,8,11,12]. Nishizawa et al. suggest that
the TTV family has three hypervariable regions (HVRs) and
the quasispecies nature of circulating TTV may help it escape
immune surveillance and establish persistent infection [7,12].
This adaptability of the HVR for viral persistence has been
well established for HCV [13,14] and HIV-1 [15].
In the present study we compared the nucleotide sequences
of the SENV-D genome obtained from serum samples of a
chronically infected patient over an interval of 12 years. By
estimating the ratio of synonymous to non-synonymous sub-
stitutions in the HVRs, we found that a positive selection was
taking place in the HVRs of SENV-D. The rate of synony-
mous substitutions for open reading frame (ORF)1 and ORF2
of SENV-D was estimated to be 7.32U1034 per site per year
on the basis of the regression analysis of phylogenetic branch
lengths using SENV-D as an outgroup. The observed muta-
tion rate is closer to that of RNA viruses, such as HCV, than
to typical DNA viruses.
2. Materials and methods
2.1. Patients and serum samples
We used sequential serum samples obtained from a patient that was
positive for SENV-D DNA by polymerase chain reaction (PCR) as
reported previously [8]. The patient (RP) with chronic posttransfusion
hepatitis C was persistently infected with SENV-D for 12 years. Three
available sera were used for determining the sequence of SEN-V ge-
nome: (1) November 30, 1978 at the initial acute phase of the infec-
tion; (2) November 22, 1987, 9 years after transfusion; (3) September
19, 1990, 12 years after transfusion. They were designated SENV-D/
RP78, SENV-D/RP87, SENV-D/RP90, respectively. Another patient
(AB) with posttransfusion non-A to E hepatitis associated with
chronic SENV-D infection was assessed. The sequence of SENV-D
was determined using two available sera: (1) December 1, 1978 at the
initial acute phase of the infection; (2) August 20, 1982, 3.7 years after
transfusion. Those sequences that were obtained from patient AB
were designated as SENV-D/AB78, SENV-D/AB82, respectively.
Those patients did not receive any blood transfusion during the in-
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terval between serum samplings. Samples were stored at 380‡C before
testing for SEN-V DNA.
2.2. PCR ampli¢cation of SEN-V and determination of the
nucleotide sequences
Nucleic acids were extracted from 100 Wl of serum by QIAamp
DNA Blood Mini Kit (Qiagen, Valencia, CA, USA). SENV-D
DNA was ampli¢ed by PCR in the presence of TaKaRa Ex Taq
(Panvera, Madison, WI, USA). PCR ampli¢cation of the partial
ORF1 sequences was performed for 40 cycles (94‡C for 30 s (plus
2 min in the ¢rst cycle); 55‡C for 60 s; 68‡C for 60 s) with the sense
primer D1224S (5P-ACGTATCCCAGAGGCAGAAAAT-3P) and the
antisense primer D2437AS (5P-ACTTGTACGTCCCGCTTGAATC-
3P). In samples of patient RP, PCR ampli¢cation of the ORF2 was
performed for 40 cycles (94‡C for 30 s (plus 2 min in the ¢rst cycle);
60‡C for 60 s; 68‡C for 60 s) with the sense primer D177S (5P-
CCGGAGGTGAGTTTACACACCG-3P) and the antisense primer
D723AS (5P-CTACCGCGGCGCCTCCTTACTGT-3P).
The size of ampli¢ed DNA fragment was con¢rmed by 1.5% aga-
rose gel electrophoresis followed by ethidium bromide staining. PCR
products were puri¢ed using the QIAquick PCR Puri¢cation Kit (Qia-
gen, Valencia, CA, USA) and directly sequenced by the BigDye Ter-
minator Cycle Sequencing Ready Reaction Kit (PE Applied Biosys-
tems, Foster City, CA, USA) using an ABI 310 DNA Sequencer.
Total sequences (1578 nt) including ORF1 (1173 nt) and ORF2
(405 nt) were available for analysis.
2.3. Nucleotide sequence data and molecular evolutionary analysis
We collected the nucleotide sequence data of the partial ORF1
region (792 nt) of TJN01 for clones that were periodically isolated
from one individual [7]. This individual was called N1 throughout this
paper. In this study, we selected one major clone each obtained at
three time points over 5.5 years. Those sequences that were obtained
from N1 were designated as TJN01/N193, TJN01/N197, and TJN01/
N198, respectively.
The DDBJ/EMBL/GenBank accession numbers of SEN-V isolates
used in this study are as follows: SENV-D/RP78 (AB062295,
AB072967), SENV-D/RP87 (AB062296, AB072968), SENV-D/RP90
(AB062297, AB072969), SENV-D/AB78 (AB072965), SENV-
D/AB82 (AB072966), SENV-D (AX025730) [1], TJN01/N193
(AB028670) [7], TJN01/N197 (AB028678), and TJN01/N198
(AB028686). The sequences were aligned with CLUSTAL W (version
1.8). The number of synonymous substitutions per potential synony-
mous site (dS) and the number of non-synonymous substitutions per
potential non-synonymous site (dN) for each set of sequences from the
di¡erent time points were calculated by using the method of Nei and
Gojobori [16] incorporating the Jukes^Cantor correction for multiple
substitutions, as implemented in the MEGA program version 2.1 [17].
On the basis of the genetic distances, a phylogenetic tree was con-
structed by the neighbor-joining method [18] and a regression analysis
was conducted to estimate the rate of synonymous substitutions in the
ORF1 (1173 nt) and ORF2 (405 nt) of SENV-D. Neutrality of each
individual was estimated by codon-based tests of selection with 1000
times bootstrap resampling tests in the MEGA program version 2.1
[17,19].
3. Results
To examine whether positive selection is operating on the
HVRs, the ratio of overall mean synonymous to non-synon-
ymous substitutions (dS/dN) in the HVRs were evaluated in
three patients (Table 1). The dS/dN ratios lower than 1.0 were
observed in samples collected at all time points in RP (0.177;
P = 0.002), AB (0.000; P = 0.001) and N1 (0.000; P = 0.042).
These data indicated that positive selection was taking place
in HVRs of SEN-V within single hosts.
A phylogenetic tree of the SEN-V sequences from a patient
(RP) with chronically infected SENV-D was constructed using
the number of synonymous substitutions per synonymous site
of available nucleotide sequences (1578 nt) in ORF1 and
ORF2 (Fig. 1). To determine a root of the phylogenetic
tree, SENV-D was used as an outgroup. The phylogenetic
tree based on the number of synonymous substitutions indi-
cated that the serial sequences formed one cluster and the
branch lengths generally increased according to the duration
after infection. The branch length of each patient RP isolate
relative to a putative common ancestor was determined. These
values were plotted against the year the sample was collected,
and the resulting relationship was evaluated by regression
analysis (Fig. 2). The slope re£ected the unit increase in sub-
stitutions over time and represented the rate of synonymous
substitutions as 7.32U1034 per site per year. All solid circles
were well within the 95% con¢dence limits.
4. Discussion
In the present study, the ratios of dS/dN using the sequence
data for the HVRs were estimated for SENV-D periodically
sampled in three patients. The dS/dN ratios were signi¢cantly
lower than 1.0 in single hosts with SENV-D infection (Table
1). It is probable that the high non-synonymous mutation rate
re£ects immune pressure exerted as the HVR resulting in the
positive selection of persistent variants. Similar immune selec-
tion has been found to take place in the V3 loop of gp120 in
HIV-1 [20], the tax gene of human T-cell leukemia virus-1
[21], and the HVR in the E2 region of HCV [22,23].
The rate of synonymous substitution for the ORF1 and
Table 1
Average synonymous and non-synonymous nucleotide substitutions within di¡erent individuals
Sample Average (S.E.M.)a dS/dN P valueb
dS dN
RP 0.009 (0.007) 0.053 (0.015) 0.177 0.002
AB 0.000 (0.000) 0.063 (0.019) 0.000 0.001
N1 0.000 (0.000) 0.014 (0.007) 0.000 0.042
aCalculated by the method of Nei and Gojobori [16] implemented in MEGA [17].
bEstimated by codon-based tests of selection with 1000 times bootstrap resampling tests [17,19].
Fig. 1. Phylogenetic tree of the SEN-V sequences from a patient
chronically infected SENV-D constructed by neighbor-joining meth-
od on the basis of synonymous substitutions per synonymous site of
available nucleotide sequences (1578 nt) in ORF1 and ORF2 using
SENV-D (AX025730) as the reference sequence. The horizontal bar
indicates the substitutions per site and the circle labeled ‘A’ indi-
cates the ancestor for SENV-D/RP.
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ORF2 (1578 nt) of SENV-D (patient RP) was estimated to be
7.32U1034 per site per year (Fig. 2). Interestingly, this value
is close to those obtained for RNA viruses that use a poly-
merase that lacks proofreading function for replication of the
virus genome: 3.92^13.08U1033 for HIV-1 [24], 3.59^
13.10U1033 for in£uenza A virus and 0.22^7.51U1033 for
HCV [25]. Although hepatitis B virus (HBV) is a DNA virus,
it is known that HBV possesses a reverse transcriptase and
that it replicates through that enzyme. The rate of substitution
for SEN-V is approximately 10-fold higher than that of HBV
(4.57U1035) [26]. Other DNA viruses mutate less frequently;
the rates of nucleotide substitution of herpes simplex virus
type 1 and human polyomavirus JC were reported to be
3.5U1038 [27] and 4U1037 [28], respectively. Thus, the syn-
onymous substitution rate of SEN-V is close to that of RNA
viruses and much higher than that of classic DNA viruses.
Recently, the rapid mutation frequencies of maize streak vi-
rus, a plant virus with single-stranded circular DNA were
reported [29]. The mutation frequencies of this virus, as de-
termined by the number of mutations relative to the consensus
divided by the number of nucleotides sequenced, were 3.8^
10.5U1034. As previously reported, the mutation rate per
base in DNA-based microbes is inversely proportional to ge-
nome size. This is consistent with the rapid substitution rate
of SEN-V since the Circoviridae are among the smallest DNA
viruses [30]. More recently, Wilson et al. have reported that
some of SEN-V DNA sequences obtained from paired serum
samples with a median of 9.3 year intervals were clustered in
each group; some subjects had persistent infection of SEN-V
[11]. The estimated substitution rates of SENV-D or -H using
the clustered paired sequences are probably more than 1034
per site per year in each subject (data not shown). This rapid
evolution suggests that SEN-V is replicated by machinery with
poor or no proofreading activity via a host DNA polymerase
complex, as evidenced by the lack of an identi¢able polymer-
ase gene within the SEN-V genome. Alternatively, it is possi-
ble that SEN-V is composed of functionally less important
genes, such as pseudogenes, that evolve faster than genes
that are more functionally relevant [31].
In summary, we have presented that positive selection could
operate in the HVRs of SEN-V within single hosts as a mech-
anism to evade immune surveillance of the host. Our results
also suggest that the evidence for the rapid substitution rate of
the SEN-V in a chronically infected patient followed for 12
years.
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